EGPSS for Weight Management in an in Vivo Human Model
A Novel Endoscopic Gastric Purse-string Suture Device for Weight Management in an in Vivo Human Model
1 other identifier
interventional
15
1 country
1
Brief Summary
ndoscopic bariatric and metabolic therapies (EBMTs) have introduced more convenient, minimally invasive, and safe approaches to weight management. Mucosal ablation of the gastric fundus has been reported to limit fundic expansion and promote satiety; however, ablation can cause perforation, infection, bleeding, and other complications. To restrain fundic expansion while minimizing surgical trauma and preserving reversibility, an endoscopic gastric purse-string suturing (EGPSS) technique was developed to reduce gastric volume. This procedure may be suitable for short-term weight management. Safety and feasibility were demonstrated in a porcine model. The present study will evaluate the feasibility of EGPSS in participants with obesity and assess histological and physiological outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
September 11, 2025
CompletedFirst Posted
Study publicly available on registry
September 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 22, 2025
September 1, 2025
1.5 years
September 11, 2025
September 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent Total Weight Loss (%TWL) measured by calibrated digital scale
Body weight recorded using a calibrated digital scale (kg). %TWL calculated as (baselineweight-follow-upweight)÷baselineweight × 100%. Measurements obtained under fasting conditions, light clothing, no shoes.
Baseline and 3 months post-procedure
Secondary Outcomes (6)
Percent Excess Weight Loss (%EWL) measured by calibrated digital scale
Baseline and 3 months
Satiety score (100-mm Visual Analog Scale, VAS) after standardized liquid meal
Baseline and 3 months
Gastric fundus volume (magnetic resonance imaging, MRI)
Baseline and 3 months
Fasting plasma ghrelin and leptin (ELISA)
Baseline and 3 months
Insulin resistance (HOMA-IR)
Baseline and 3 months
- +1 more secondary outcomes
Study Arms (1)
Operation group
EXPERIMENTALPatients will undergo endoscopic gastric purse-string suturing procedure under endoscope by skilled endoscopist
Interventions
A dual-tail endoloop will be introduced into the stomach with endoscopic forceps, and will be secured to the gastric wall using endoscopic clips. An endoscope hook was used to tighten both tails of the endoloop until all the clips converged.
Eligibility Criteria
You may qualify if:
- Patients with a body mass index (BMI) of 24-35 kg / m²;
- Patients accepted Lifestyle modifications, pharmacological interventions for weight loss which were unsuccessful or experienced a weight rebound;
- Patients willing to loss weight;
- Obese patients with metabolic disorders.
You may not qualify if:
- Women who are planning to conceive, pregnant, or breastfeeding;
- Patients who are suffering from severe organ failure requiring hospitalization;
- Patients who have undergone gastrectomy;
- Patients allergic to anesthetics.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Liu Yanlead
Study Sites (1)
The fifth Medical Center of Chinese PLA General Hospital
Beijing, Beijing Municipality, 100071, China
Related Publications (4)
Bluher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019 May;15(5):288-298. doi: 10.1038/s41574-019-0176-8.
PMID: 30814686BACKGROUNDMaselli DB, Donnangelo LL, Coan B, McGowan CE. How to establish an endoscopic bariatric practice. World J Gastrointest Endosc. 2024 Apr 16;16(4):178-186. doi: 10.4253/wjge.v16.i4.178.
PMID: 38680199BACKGROUNDSimons M, Sharaiha RZ. Updates in metabolic bariatric endoscopy. Dig Endosc. 2024 Feb;36(2):107-115. doi: 10.1111/den.14633. Epub 2023 Aug 9.
PMID: 37405807BACKGROUNDVargas EJ, Rizk M, Gomez-Villa J, Edwards PK, Jaruvongvanich V, Storm AC, Acosta A, Lake D, Fidler J, Bharucha AE, Camilleri M, Abu Dayyeh BK. Effect of endoscopic sleeve gastroplasty on gastric emptying, motility and hormones: a comparative prospective study. Gut. 2023 Jun;72(6):1073-1080. doi: 10.1136/gutjnl-2022-327816. Epub 2022 Oct 14.
PMID: 36241388BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yan Liu
Beijing 302 Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director, Head of Gastroenterology, Principal Investigator, Clinical Professor
Study Record Dates
First Submitted
September 11, 2025
First Posted
September 22, 2025
Study Start
July 1, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
September 22, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share